UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________

FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):
August 4, 2021

CHIMERA INVESTMENT CORPORATION 
(Exact name of registrant as specified in its charter)
Maryland 1-33796 26-0630461
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)

520 Madison Avenue, 32nd Fl
New York New York 10022
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:   (212) 626-2300  

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share CIM New York Stock Exchange
8.00% Series A Cumulative Redeemable Preferred Stock CIM PRA New York Stock Exchange
8.00% Series B Cumulative Fixed-to-Floating Rate Redeemable Preferred Stock CIM PRB New York Stock Exchange
7.75% Series C Cumulative Fixed-to-Floating Rate Redeemable Preferred Stock CIM PRC New York Stock Exchange
8.00% Series D Cumulative Fixed-to-Floating Rate Redeemable Preferred Stock CIM PRD New York Stock Exchange
Registrant's Web site address: www.chimerareit.com
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)




Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).        

Emerging growth company    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    




Item 2.02. Results of Operations and Financial Condition

    On August 4, 2021, the registrant issued a press release announcing its financial results for the quarter ended June 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this report.

    On August 4, 2021, the registrant posted supplemental financial information on the News & Events - Press Releases section of its website (www.chimerareit.com). A copy of the supplemental financial information is furnished as Exhibit 99.2 to this report and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1
99.2





SIGNATURES
               Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
      Chimera Investment Corporation
       By: /s/ Kelley Kortman  
             Name:    Kelley Kortman            
             Title:    Chief Accounting Officer
Date: August 4, 2021



CHIMERALOGOA18A.JPG
PRESS RELEASE
NYSE: CIM    
CHIMERA INVESTMENT CORPORATION
520 Madison Avenue
New York, New York 10022
_________________________________________________________________________________________________

Investor Relations
888-895-6557
www.chimerareit.com
FOR IMMEDIATE RELEASE
CHIMERA INVESTMENT CORPORATION REPORTS 2ND QUARTER 2021 EARNINGS
2ND QUARTER GAAP NET INCOME OF $0.60 PER COMMON SHARE
2ND QUARTER CORE EARNINGS(1) OF $0.54 PER COMMON SHARE WHICH INCLUDES $0.16 OF INCOME FROM SECURITIES THAT HAVE BEEN CALLED
GAAP BOOK VALUE OF $11.45 PER COMMON SHARE
NEW YORK - (BUSINESS WIRE) - Chimera Investment Corporation (NYSE:CIM) today announced its financial results for the second quarter ended June 30, 2021. The Company’s GAAP net income for the second quarter was $145 million, or $0.60 per common share. Core earnings(1) for the second quarter ended June 30, 2021 was $130 million, or $0.54 per common share.

“This quarter we continued to make significant progress towards optimization of our liability structure. For the first six months of 2021 we successfully refinanced 12 legacy CIM securitizations supporting more than $5.6 billion loans”, said Mohit Marria, Chimera’s CEO and Chief Investment Officer. “The result of these transactions has lowered our overall cost of debt by approximately 245 basis points and we expect this cost savings to continue to benefit our shareholders in the future.”

(1) Core earnings per adjusted diluted common share is a non-GAAP measure. See additional discussion on page 5.
1


Other Information
Chimera Investment Corporation is a publicly traded real estate investment trust, or REIT, that is primarily engaged in the business of investing directly or indirectly through our subsidiaries, on a leveraged basis, in a diversified portfolio of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency CMBS, Agency RMBS, and other real estate related securities.

CHIMERA INVESTMENT CORPORATION
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(dollars in thousands, except share and per share data)
(Unaudited)
June 30, 2021 December 31, 2020
Cash and cash equivalents $ 346,951  $ 269,090 
Non-Agency RMBS, at fair value (net of allowance for credit losses of $508 thousand and $180 thousand, respectively) 1,919,668  2,150,714 
Agency RMBS, at fair value 76,820  90,738 
Agency CMBS, at fair value 1,236,507  1,740,368 
Loans held for investment, at fair value 12,150,868  13,112,129 
Accrued interest receivable 75,314  81,158 
Other assets 53,931  78,822 
Total assets (1)
$ 15,860,059  $ 17,523,019 
Liabilities:    
Secured financing agreements ($4.8 billion and $6.7 billion pledged as collateral, respectively) $ 3,554,428  $ 4,636,847 
Securitized debt, collateralized by Non-Agency RMBS ($453 million and $505 million pledged as collateral, respectively) 99,559  113,433 
Securitized debt at fair value, collateralized by Loans held for investment ($11.5 billion and $12.4 billion pledged as collateral, respectively) 8,371,511  8,711,677 
Long term debt 20,550  51,623 
Payable for investments purchased 58,467  106,169 
Accrued interest payable 23,128  40,950 
Dividends payable 87,050  77,213 
Accounts payable and other liabilities 17,935  5,721 
Total liabilities (1)
$ 12,232,628  $ 13,743,633 
Stockholders' Equity:    
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:
8.00% Series A cumulative redeemable: 5,800,000 shares issued and outstanding, respectively ($145,000 liquidation preference) $ 58  $ 58 
8.00% Series B cumulative redeemable: 13,000,000 shares issued and outstanding, respectively ($325,000 liquidation preference) 130  130 
7.75% Series C cumulative redeemable: 10,400,000 shares issued and outstanding, respectively ($260,000 liquidation preference) 104  104 
8.00% Series D cumulative redeemable: 8,000,000 shares issued and outstanding, respectively ($200,000 liquidation preference) 80  80 
Common stock: par value $0.01 per share; 500,000,000 shares authorized, 235,557,640 and 230,556,760 shares issued and outstanding, respectively 2,356  2,306 
Additional paid-in-capital 4,352,986  4,538,029 
Accumulated other comprehensive income 456,113  558,096 
Cumulative earnings 4,202,806  3,881,894 
Cumulative distributions to stockholders (5,387,202) (5,201,311)
Total stockholders' equity $ 3,627,431  $ 3,779,386 
Total liabilities and stockholders' equity $ 15,860,059  $ 17,523,019 
(1) The Company's consolidated statements of financial condition include assets of consolidated variable interest entities (“VIEs”) that can only be used to settle obligations and liabilities of the VIE for which creditors do not have recourse to the primary beneficiary (Chimera Investment Corporation). As of June 30, 2021, and December 31, 2020, total assets of consolidated VIEs were $11,090,458 and $12,165,017, respectively, and total liabilities of consolidated VIEs were $7,786,837 and $8,063,110, respectively.
2



CHIMERA INVESTMENT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(dollars in thousands, except share and per share data)
(Unaudited)
  For the Quarters Ended For the Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Net interest income:
Interest income (1)
$ 252,677  $ 245,922  $ 495,805  $ 546,189 
Interest expense (2)
80,610  129,256  188,677  271,339 
Net interest income 172,067  116,666  307,128  274,850 
Increase/(decrease) in provision for credit losses 453  (4,497) 327  1,817 
Other investment gains (losses):  
Net unrealized gains (losses) on derivatives —  —  —  201,000 
Realized gains (losses) on terminations of interest rate swaps —  —  —  (463,966)
Net realized gains (losses) on derivatives —  —  —  (41,086)
Net gains (losses) on derivatives —  —  —  (304,052)
Net unrealized gains (losses) on financial instruments at fair value 36,108  (171,921) 306,120  (432,809)
Net realized gains (losses) on sales of investments 7,517  26,380  45,313  102,234 
Gains (losses) on extinguishment of debt (21,777) 459  (258,914) 459 
Total other gains (losses) 21,848  (145,082) 92,519  (634,168)
Other expenses:    
Compensation and benefits 9,230  10,255  22,669  23,190 
General and administrative expenses 6,173  5,963  11,371  11,100 
Servicing and asset manager fees 9,081  10,072  18,362  20,601 
Transaction expenses 5,745  4,710  22,182  9,616 
Total other expenses 30,229  31,000  74,584  64,507 
Income (loss) before income taxes 163,233  (54,919) 324,736  (425,642)
Income tax expense (benefit) (88) 36  3,824  68 
Net income (loss) $ 163,321  $ (54,955) $ 320,912  $ (425,710)
Dividends on preferred stock 18,438  18,438  36,875  36,875 
Net income (loss) available to common shareholders $ 144,883  $ (73,393) $ 284,037  $ (462,585)
Net income (loss) per share available to common shareholders:
Basic $ 0.63  $ (0.37) $ 1.23  $ (2.39)
Diluted $ 0.60  $ (0.37) $ 1.14  $ (2.39)
Weighted average number of common shares outstanding:
Basic 231,638,042  199,282,790  231,105,595  193,150,696 
Diluted 241,739,536  199,282,790  251,723,940  193,150,696 

(1) Includes interest income of consolidated VIEs of $149,115 and $169,127 for the quarters ended June 30, 2021 and 2020, respectively, and $307,214 and $343,809 for the six months ended June 30, 2021 and 2020, respectively.

(2) Includes interest expense of consolidated VIEs of $50,935 and $70,816 for the quarters ended June 30, 2021 and 2020, respectively, and $116,141 and $135,445 for the six months ended June 30, 2021 and 2020, respectively.


3


CHIMERA INVESTMENT CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(dollars in thousands, except share and per share data)
(Unaudited)
For the Quarters Ended For the Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Comprehensive income (loss):  
Net income (loss) $ 163,321  $ (54,955) $ 320,912  $ (425,710)
Other comprehensive income:  
Unrealized gains (losses) on available-for-sale securities, net (26,215) 61,399  (64,867) (137,805)
Reclassification adjustment for net realized losses (gains) included in net income (11,323) (26,380) (37,116) (33,021)
Other comprehensive income (loss) (37,538) 35,019  (101,983) (170,826)
Comprehensive income (loss) before preferred stock dividends $ 125,783  $ (19,936) $ 218,929  $ (596,536)
Dividends on preferred stock $ 18,438  $ 18,438  $ 36,875  $ 36,875 
Comprehensive income (loss) available to common stock shareholders $ 107,345  $ (38,374) $ 182,054  $ (633,411)


4


Core earnings
Core earnings is a non-GAAP measure and is defined as GAAP net income excluding unrealized gains or losses on financial instruments carried at fair value with changes in fair value recorded in earnings, realized gains or losses on the sales of investments, gains or losses on the extinguishment of debt, interest expense on long term debt, changes in the provision for credit losses, and transaction expenses incurred. In addition, stock compensation expense charges incurred on awards to retirement eligible employees is reflected as an expense over a vesting period (36 months) rather than reported as an immediate expense.

As defined, core earnings is the Economic net interest income, as defined previously, reduced by compensation and benefits expenses (adjusted for awards to retirement eligible employees), general and administrative expenses, servicing and asset manager fees, income tax benefits or expenses incurred during the period, as well as the preferred dividend charges. We believe that the presentation of core earnings provides us and investors with a useful measure, but has important limitations. We believe core earnings as described above helps us and investors evaluate our financial performance period over period without the impact of certain transactions but, is of limited usefulness as an analytical tool. Therefore, core earnings should not be viewed in isolation and is not a substitute for net income or net income per basic share computed in accordance with GAAP. In addition, our methodology for calculating core earnings may differ from the methodologies employed by other REITs to calculate the same or similar supplemental performance measures, and accordingly, our reported core earnings may not be comparable to the core earnings reported by other REITs.

The following table provides GAAP measures of net income and net income per diluted share available to common stockholders for the periods presented and details with respect to reconciling the line items to core earnings and related per average diluted common share amounts. Core earnings is presented on an adjusted dilutive shares basis. Certain prior period amounts have been reclassified to conform to the current period's presentation.

  For the Quarters Ended
  June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020
  (dollars in thousands, except per share data)
GAAP Net income available to common stockholders $ 144,883  $ 139,153  $ 128,797  $ 348,891  $ (73,393)
Adjustments:  
Net unrealized (gains) losses on financial instruments at fair value (36,108) (270,012) (61,379) (260,766) 171,921 
Net realized (gains) losses on sales of investments (7,517) (37,796) 329  (65,041) (26,380)
(Gains) losses on extinguishment of debt 21,777  237,137  (919) 55,794  (459)
Interest expense on long term debt 959  1,076  1,197  1,495  4,391 
Increase (decrease) in provision for credit losses 453  (126) 13  (1,650) (4,497)
Transaction expenses 5,745  16,437  3,827  1,624  4,710 
Stock Compensation expense for retirement eligible awards (361) 661  (225) (275) (273)
Core Earnings $ 129,831  $ 86,530  $ 71,640  $ 80,072  $ 76,020 
GAAP net income per diluted common share $ 0.60  $ 0.54  $ 0.49  $ 1.32  $ (0.37)
Core earnings per adjusted diluted common share $ 0.54  $ 0.36  $ 0.29  $ 0.33  $ 0.32 


5


The following tables provide a summary of the Company’s MBS portfolio at June 30, 2021 and December 31, 2020.

  June 30, 2021
  Principal or Notional Value
at Period-End
(dollars in thousands)
Weighted Average Amortized
Cost Basis
Weighted Average Fair Value Weighted Average
Coupon
Weighted Average Yield at Period-End (1)
Non-Agency RMBS        
Senior
$ 1,405,783  $ 49.69  79.45  4.4  % 17.4  %
Subordinated
827,198  67.30  73.04  3.9  % 6.5  %
Interest-only
4,217,507  5.06  4.71  1.7  % 12.7  %
Agency RMBS          
Interest-only 1,164,844  9.47  6.60  1.3  % 1.4  %
Agency CMBS
Project loans
974,756  101.78  112.25  4.2  % 4.1  %
Interest-only
2,412,480  5.71  5.90  0.7  % 4.6  %
(1) Bond Equivalent Yield at period end.

  December 31, 2020
  Principal or Notional Value at Period-End
(dollars in thousands)
Weighted Average Amortized
Cost Basis
Weighted Average Fair Value Weighted Average
Coupon
Weighted Average Yield at Period-End (1)
Non-Agency RMBS        
Senior
$ 1,560,135  $ 50.65  $ 81.90  4.5  % 16.9  %
Subordinated
905,674  62.46  67.43  3.8  % 6.3  %
Interest-only
5,628,240  4.43  4.66  1.5  % 16.2  %
Agency RMBS          
Interest-only
1,262,963  9.41  7.18  1.7  % 1.6  %
Agency CMBS
Project loans
1,527,621  101.81  112.23  4.1  % 3.8  %
Interest-only
1,326,665  1.78  1.95  0.6  % 8.4  %
(1) Bond Equivalent Yield at period end.
6


At June 30, 2021 and December 31, 2020, the secured financing agreements collateralized by MBS and Loans held for investment had the following remaining maturities and borrowing rates.

  June 30, 2021 December 31, 2020
  (dollars in thousands)
Principal (1)
Weighted Average Borrowing Rates Range of Borrowing Rates
Principal (1)
Weighted Average Borrowing Rates Range of Borrowing Rates
Overnight $ 105,673  0.73% 0.70% - 0.78% $ —  NA NA
1 to 29 days 1,248,179  0.84% 0.08% - 3.25% 1,521,134  0.38% 0.20% - 2.72%
30 to 59 days 267,897  1.57% 1.38% - 1.96% 481,257  4.35% 2.42% - 6.61%
60 to 89 days 459,140  2.16% 1.38% - 2.44% 352,684  2.78%  1.34% - 6.30%
90 to 119 days 51,944  1.82% 1.82% - 1.82% 301,994  7.97% 7.97% - 7.97%
120 to 180 days 122,765  1.77%  1.77% - 1.77% 595,900  5.29% 2.40% - 6.26%
180 days to 1 year 146,296  1.79%  0.95% - 1.95% 345,204  3.60% 3.25% - 4.50%
1 to 2 years 837,513  3.96% 2.85% - 4.38% —  NA NA
2 to 3 years —  NA NA 642,696  4.91% 1.65% - 7.00%
Greater than 3 years 315,021  5.56%  5.56% - 5.56% 395,978  5.56% 5.56% - 5.56%
Total $ 3,554,428  2.30% $ 4,636,847  3.41%
(1) The values for secured financing agreements in the table above is net of $4 million and $8 million of deferred financing cost as of June 30, 2021 and December 31, 2020, respectively.

The following table summarizes certain characteristics of our portfolio at June 30, 2021 and December 31, 2020.

June 30, 2021 December 31, 2020
GAAP Leverage at period-end  3.3:1 3.6:1
GAAP Leverage at period-end (recourse)  1.0:1 1.2:1

June 30, 2021 December 31, 2020 June 30, 2021 December 31, 2020
Portfolio Composition Amortized Cost Fair Value
Non-Agency RMBS
10.4  % 10.2  % 12.5  % 12.6  %
Senior
5.0  % 5.0  % 7.3  % 7.5  %
Subordinated
3.9  % 3.6  % 3.9  % 3.6  %
Interest-only
1.5  % 1.6  % 1.3  % 1.5  %
Agency RMBS
0.8  % 0.7  % 0.5  % 0.5  %
Pass-through
—  % —  % —  % —  %
Interest-only
0.8  % 0.7  % 0.5  % 0.5  %
Agency CMBS
8.0  % 10.0  % 8.0  % 10.2  %
Project loans
7.0  % 9.9  % 7.1  % 10.0  %
Interest-only
1.0  % 0.1  % 0.9  % 0.2  %
Loans held for investment 80.8  % 79.1  % 79.0  % 76.7  %
Fixed-rate percentage of portfolio
95.0  % 94.9  % 93.7  % 93.2  %
Adjustable-rate percentage of portfolio
5.0  % 5.1  % 6.3  % 6.8  %

7


Economic Net Interest Income

Our “Economic net interest income” is a non-GAAP financial measure, that equals interest income, less interest expense and realized losses on our interest rate swaps. Realized losses on our interest rate swaps are the periodic net settlement payments made or received.  For the purpose of computing economic net interest income and ratios relating to cost of funds measures throughout this section, interest expense includes net payments on our interest rate swaps, which is presented as a part of Realized gains (losses) on derivatives in our Consolidated Statements of Operations and Comprehensive Income. Interest rate swaps are used to manage the increase in interest paid on repurchase agreements in a rising rate environment. Presenting the net contractual interest payments on interest rate swaps with the interest paid on interest-bearing liabilities reflects our total contractual interest payments. We believe this presentation is useful to investors because it depicts the economic value of our investment strategy by showing actual interest expense and net interest income. Where indicated, interest expense, including interest payments on interest rate swaps, is referred to as economic interest expense. Where indicated, net interest income reflecting interest payments on interest rate swaps, is referred to as economic net interest income.

The following table reconciles the GAAP and non-GAAP measurements reflected in the Management’s Discussion and Analysis of Financial Condition and Results of Operations.

  GAAP
Interest
Income
GAAP
Interest
Expense
Net Realized (Gains)
Losses on Interest Rate Swaps
Interest Expense on Long Term Debt Economic Interest
Expense
GAAP Net Interest
Income
Net Realized
Gains (Losses) on Interest Rate Swaps
Other (1)
Economic
Net
Interest
Income
For the Quarter Ended June 30, 2021 $ 252,677  $ 80,610  $ —  $ (959) $ 79,651  $ 172,067  $ —  $ 936  $ 173,003 
For the Quarter Ended March 31, 2021 $ 243,127  $ 108,066  $ —  $ (1,076) $ 106,990  $ 135,061  $ —  $ 1,065  $ 136,126 
For the Quarter Ended December 31, 2020 $ 236,156  $ 120,285  $ —  $ (1,197) $ 119,088  $ 115,871  $ —  $ 1,177  $ 117,048 
For the Quarter Ended September 30, 2020 $ 247,905  $ 124,557  $ —  $ (1,495) $ 123,062  $ 123,348  $ —  $ 1,487  $ 124,835 
For the Quarter Ended June 30, 2020 $ 245,922  $ 129,256  $ —  $ (4,391) $ 124,865  $ 116,666  $ —  $ 4,358  $ 121,024 
(1) Primarily interest expense on Long term debt and interest income on cash and cash equivalents.






8


The table below shows our average earning assets held, interest earned on assets, yield on average interest earning assets, average debt balance, economic interest expense, economic average cost of funds, economic net interest income, and net interest rate spread for the periods presented.

  For the Quarter Ended
June 30, 2021 June 30, 2020
(dollars in thousands) (dollars in thousands)
  Average
Balance
Interest Average
Yield/Cost
Average
Balance
Interest Average
Yield/Cost
Assets:            
Interest-earning assets (1):
           
Agency RMBS $ 111,271  $ 346  1.2  % $ 132,915  $ 682  2.1  %
Agency CMBS 1,106,926  29,985  10.8  % 2,223,629  20,161  3.6  %
Non-Agency RMBS 1,499,262  69,716  18.6  % 1,758,255  57,515  13.1  %
Loans held for investment 11,744,270  152,607  5.2  % 13,202,723  167,531  5.1  %
Total $ 14,461,729  $ 252,654  7.0  % $ 17,317,522  $ 245,889  5.7  %
Liabilities and stockholders' equity:            
Interest-bearing liabilities:             
Secured financing agreements collateralized by:
Agency RMBS $ 60,528  $ 116  0.8  % $ 77,114  $ 228  1.2  %
Agency CMBS 1,004,043  296  0.1  % 2,188,202  2,346  0.4  %
Non-Agency RMBS 852,582  7,616  3.6  % 1,292,934  22,408  6.9  %
Loans held for investment 1,875,395  16,483  3.5  % 2,978,013  27,338  3.7  %
Securitized debt 8,629,541  55,140  2.6  % 8,459,641  72,545  3.4  %
Total $ 12,422,089  $ 79,651  2.6  % $ 14,995,904  $ 124,865  3.3  %
Economic net interest income/net interest rate spread   $ 173,003  4.4  % $ 121,024  2.4  %
Net interest-earning assets/net interest margin $ 2,039,640    4.8  % $ 2,321,618  2.8  %
Ratio of interest-earning assets to interest bearing liabilities 1.16      1.15   
(1) Interest-earning assets at amortized cost

The table below shows our Net Income and Economic Net Interest Income as a percentage of average stockholders' equity and Core Earnings as a percentage of average common stockholders' equity. Return on average equity is defined as our GAAP net income (loss) as a percentage of average equity.  Average equity is defined as the average of our beginning and ending stockholders' equity balance for the period reported. Economic Net Interest Income and Core Earnings are non-GAAP measures as defined in previous sections.

  Return on Average Equity Economic Net Interest Income/Average Equity * Core Earnings/Average Common Equity
  (Ratios have been annualized)
For the Quarter Ended June 30, 2021 18.16  % 19.24  % 19.47  %
For the Quarter Ended March 31, 2021 17.16  % 14.82  % 12.62  %
For the Quarter Ended December 31, 2020 15.76  % 12.53  % 10.21  %
For the Quarter Ended September 30, 2020 41.43  % 14.08  % 12.24  %
For the Quarter Ended June 30, 2020 (6.62) % 14.58  % 12.72  %
* Includes effect of realized losses on interest rate swaps and excludes long term debt expense.

9


The following table presents changes to Accretable Discount (net of premiums) as it pertains to our Non-Agency RMBS portfolio, excluding premiums on IOs, during the previous five quarters.

  For the Quarters Ended
(dollars in thousands)
Accretable Discount (Net of Premiums) June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020
Balance, beginning of period $ 358,562  $ 409,690  $ 422,981  $ 410,447  $ 438,232 
Accretion of discount (37,986) (24,023) (21,281) (20,045) (22,508)
Purchases (3,453) —  758  2,096  — 
Sales and deconsolidation (17,123) (41,651) 98  —  (23,425)
Transfers from/(to) credit reserve, net 38,024  14,546  7,134  30,483  18,148 
Balance, end of period $ 338,024  $ 358,562  $ 409,690  $ 422,981  $ 410,447 

Disclaimer
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “target,” “assume,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believe,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among other things, those described in our most recent Annual Report on Form 10-K, and any subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, under the caption “Risk Factors.” Factors that could cause actual results to differ include, but are not limited to: our business and investment strategy; our ability to accurately forecast the payment of future dividends on our common and preferred stock, and the amount of such dividends; our ability to determine accurately the fair market value of our assets; availability of investment opportunities in real estate-related and other securities, including our valuation of potential opportunities that may arise as a result of current and future market dislocations; effect of the novel coronavirus (or COVID-19) pandemic on real estate market, financial markets and our Company, including the impact on the value, availability, financing and liquidity of mortgage assets; how COVID-19 may affect us, our operations and our personnel; our expected investments; changes in the value of our investments, including negative changes resulting in margin calls related to the financing of our assets; changes in interest rates and mortgage prepayment rates; prepayments of the mortgage and other loans underlying our mortgage-backed securities, or RMBS, or other asset-backed securities, or ABS; rates of default, delinquencies or decreased recovery rates on our investments; general volatility of the securities markets in which we invest; our ability to maintain existing financing arrangements and our ability to obtain future financing arrangements; our ability to effect our strategy to securitize residential mortgage loans; interest rate mismatches between our investments and our borrowings used to finance such purchases; effects of interest rate caps on our adjustable-rate investments; the degree to which our hedging strategies may or may not protect us from interest rate volatility; the impact of and changes to various government programs, including in response to COVID-19; impact of and changes in governmental regulations, tax law and rates, accounting guidance, and similar matters; market trends in our industry, interest rates, the debt securities markets or the general economy; estimates relating to our ability to make distributions to our stockholders in the future; our understanding of our competition; availability of qualified personnel; our ability to maintain our classification as a real estate investment trust, or, REIT, for U.S. federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended, or 1940 Act; our expectations regarding materiality or significance; and the effectiveness of our disclosure controls and procedures.
Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Chimera does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Additional information concerning these and other risk factors is contained in Chimera’s most recent filings with the Securities and Exchange Commission (SEC). All subsequent written and oral forward-looking statements concerning Chimera or matters attributable to Chimera or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above.
10


Readers are advised that the financial information in this press release is based on company data available at the time of this presentation and, in certain circumstances, may not have been audited by the Company’s independent auditors.


11
FINANCIAL SUPPLEMENT 2nd Quarter 2021


 
Information is unaudited, estimated and subject to change. DISCLAIMER This presentation includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as “goal” “expect,” “target,” “assume,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believe,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among other things, those described in our most recent Annual Report on Form 10-K, and any subsequent Quarterly Reports on Form 10-Q and Current Report on Form 8-K, under the caption “Risk Factors.” Factors that could cause actual results to differ include, but are not limited to:our business and investment strategy; our ability to accurately forecast the payment of future dividends on our common and preferred stock, and the amount of such dividends; our ability to determine accurately the fair market value of our assets; availability of investment opportunities in real estate-related and other securities, including our valuation of potential opportunities that may arise as a result of current and future market dislocations; effect of the novel coronavirus (or COVID-19) pandemic on real estate market, financial markets and our Company, including the impact on the value, availability, financing and liquidity of mortgage assets; how COVID-19 may affect us, our operations and our personnel; our expected investments; changes in the value of our investments, including negative changes resulting in margin calls related to the financing of our assets; changes in interest rates and mortgage prepayment rates; prepayments of the mortgage and other loans underlying our mortgage-backed securities, or RMBS, or other asset-backed securities, or ABS; rates of default, delinquencies or decreased recovery rates on our investments; general volatility of the securities markets in which we invest; our ability to maintain existing financing arrangements and our ability to obtain future financing arrangements; our ability to effect our strategy to securitize residential mortgage loans; interest rate mismatches between our investments and our borrowings used to finance such purchases; effects of interest rate caps on our adjustable-rate investments; the degree to which our hedging strategies may or may not protect us from interest rate volatility; the impact of and changes to various government programs, including in response to COVID-19; impact of and changes in governmental regulations, tax law and rates, accounting guidance, and similar matters; market trends in our industry, interest rates, the debt securities markets or the general economy; estimates relating to our ability to make distributions to our stockholders in the future; our understanding of our competition; availability of qualified personnel; our ability to maintain our classification as a real estate investment trust, or, REIT, for U.S. federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended, or 1940 Act; our expectations regarding materiality or significance; and the effectiveness of our disclosure controls and procedures. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Chimera does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Additional information concerning these and other risk factors is contained in Chimera’s most recent filings with the Securities and Exchange Commission (SEC). All subsequent written and oral forward-looking statements concerning Chimera or matters attributable to Chimera or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. This presentation may include industry and market data obtained through research, surveys, and studies conducted by third parties and industry publications. We have not independently verified any such market and industry data from third-party sources. This presentation is provided for discussion purposes only and may not be relied upon as legal or investment advice, nor is it intended to be inclusive of all the risks and uncertainties that should be considered. This presentation does not constitute an offer to purchase or sell any securities, nor shall it be construed to be indicative of the terms of an offer that the parties or their respective affiliates would accept. Readers are advised that the financial information in this presentation is based on company data available at the time of this presentation and, in certain circumstances, may not have been audited by the company’s independent auditors.


 
Information is unaudited, estimated and subject to change. 2 PORTFOLIO COMPOSITION 93% of Chimera's equity capital is allocated to mortgage credit Billions 3.4 2.6 1.0 8.5 Equity Recourse Non-Recourse Residential Mortgage Credit Portfolio Agency MBS Portfolio 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Total Assets: 14.1 billion Total Assets: 1.3 billion All data is shown at carrying value as of June 30, 2021 Equity Recourse Non-Recourse


 
Information is unaudited, estimated and subject to change. 3 12% 9% 79% Non-Agency MBS Agency CMBS and RMBS Loan Portfolio GAAP ASSET ALLOCATION Based on fair value. 12% 9% 79% Non-Agency MBS Agency CMBS and RMBS Loan Portfolio June 30, 2021 March 31, 2021 Chimera continues to focus on its Residential Credit portfolios Total Portfolio: $15.4 billion Total Portfolio: $16.3 billion


 
Information is unaudited, estimated and subject to change. 4 21% 8% 1%70% Non-Agency and Loans Secured Financing (1) Agency Secured Financing Non-Recourse Debt, Securitized RMBS Non-Recourse Debt, Securitized Loans GAAP FINANCING SOURCES 23% 9% 1%68% Non-Agency and Loans Secured Financing (1) Agency Secured Financing Non-Recourse Debt, Securitized RMBS Non-Recourse Debt, Securitized Loans (1) Includes secured financing of retained tranches from loan securitizations that are eliminated in consolidation. Chimera optimized its Non-Agency funding by reducing borrowing rates and increasing non-recourse debt June 30, 2021 March 31, 2021 Total Portfolio: $12.0 billion Total Portfolio: $12.9 billion (Rate: 2.5%) (Rate: 2.6%) (Rate: 0.2%) (Rate: 3.1%) (Rate: 0.2%) (Rate: 3.7%)


 
Information is unaudited, estimated and subject to change. 5 NON-AGENCY FINANCING Chimera continues to focus on longer term and non-mark- to-market financing for its non-agency portfolio M ill io ns 1,153 — 121 591 175 Mark-to-Market Limited Mark-to-Market Non Mark-to-Market 0 - 3 Months 3 - 6 Months 6 - 12 Months Greater Than 12 Months — 250 500 750 1,000 1,250 M ill io ns 1,110 225 477 562 Mark-to-Market Limited Mark-to-Market Non Mark-to-Market 0 - 3 Months 3 - 6 Months 6 - 12 Months Greater Than 12 Months — 250 500 750 1,000 1,250 June 30, 2021 March 31, 2021 Total Non-Agency Secured Financing: $2.1 billion(1) Total Non-Agency Secured Financing: $2.4 billion(1) (1) Excludes secured financing on residential mortgage loans. 44 26


 
Information is unaudited, estimated and subject to change. 6 RESIDENTIAL MORTGAGE CREDIT PORTFOLIO AGENCY PORTFOLIO(1) TOTAL PORTFOLIO GROSS ASSET YIELD: 6.7% 10.0% 7.0% FINANCING COSTS 2.8% 0.2% 2.6% NET INTEREST SPREAD: 3.9% 9.8% 4.4% NET INTEREST MARGIN: 4.3% 9.8% 4.8% All data based on the quarter ended June 30, 2021 (1) Includes $21 million of additional income received from prepayment penalties. Gross Asset Yield is approximately 3.0% excluding these items. NET INVESTMENT ANALYSIS Strong net interest spread resulting from a reduction in financing cost


 
Information is unaudited, estimated and subject to change. 7 Chimera Subsidiaries Securitization Trusts (1) Financing Trusts Total Investments Non-Agency RMBS, at fair value $ 1,466,778 $ 452,889 $ — $ 1,919,667 Agency RMBS, at fair value 76,820 — — 76,820 Agency CMBS, at fair value 1,236,507 — — 1,236,507 Residential Mortgage Loans — 11,478,042 672,825 12,150,867 Total Invested Assets $ 2,780,105 $ 11,930,931 $ 672,825 $ 15,383,861 Securitized Debt (Non-Recourse), collateralized by: Non-Agency RMBS $ — $ 99,559 $ — $ 99,559 Residential Mortgage Loans — 8,371,511 — 8,371,511 Total Securitized Debt (Non-recourse) $ — $ 8,471,070 $ — $ 8,471,070 Invested Assets less Securitized Debt $ 2,780,105 $ 3,459,861 $ 672,825 $ 6,912,791 Secured Financing Agreements (Recourse): Non-Agency RMBS $ 718,411 $ 113,094 $ — $ 831,505 Agency RMBS 57,025 — — 57,025 Agency CMBS 943,213 — — 943,213 Residential Mortgage Loans — 1,233,466 489,219 1,722,685 Total Secured Financing Agreements $ 1,718,649 $ 1,346,560 $ 489,219 $ 3,554,428 Net Assets $ 1,061,456 $ 2,113,301 $ 183,606 $ 3,358,363 All data as of June 30, 2021 $ in thousands (1) Includes $901 million of loans account for as secured borrowings and $703 million of securitized debt (non-recourse). NET ASSET BREAKDOWN Chimera invests in RMBS securities and securities created through the CIM Sponsored securitizations. Loans are financed through Financing Trusts.


 
Information is unaudited, estimated and subject to change. 8 $977 Million Loan Securitization with a Weighted Average Coupon of 6.2% Deal Name Securitized Debt (UPB) Average Yield Legacy Deal CIM 2017-1, 5, 6 $681,798 4.1% 2021 Securitization CIM 2021-R3, NR3 $812,936 2.1% Net Impact $131,138 (2.0)% $546 Million Loan Securitization with a Weighted Average Coupon of 6.2% Deal Name Securitized Debt (UPB) Average Yield Legacy Deal CIM 2018-R1, R2, R4 $365,648 3.8% 2021 Securitization CIM 2021-R4 $463,831 2.0% Net Impact $98,183 (1.8)% *All secured financing on retained tranches from 2021 securitizations is Limited-Mark-to-Market with a weighted average maturity of 12 months RE-SECURITIZATION ACTIVITY Chimera achieved higher advance rates on new securitizations while reducing securitized debt expense All data as of securitization closing date. $ in thousands


 
Information is unaudited, estimated and subject to change. 9 VINTAGE DEAL TOTAL ORIGINAL FACE TOTAL OF TRANCHES SOLD TOTAL OF TRANCHES RETAINED TOTAL REMAINING FACE REMAINING FACE OF TRANCHES SOLD REMAINING FACE OF TRANCHES RETAINED 2021 CIM 2021-R4 $545,684 $463,831 $81,853 $545,684 $463,831 $81,853 2021 CIM 2021-R3 859,735 730,775 128,960 826,252 696,276 129,976 2021 CIM 2021-NR3 117,373 82,161 35,212 112,239 77,773 34,466 2021 CIM 2021-R2 1,497,213 1,272,631 224,582 1,403,960 1,176,698 227,262 2021 CIM 2021-NR2 240,425 180,318 60,107 228,432 168,033 60,399 2021 CIM 2021-R1 2,098,584 1,783,797 314,787 1,941,194 1,621,834 319,360 2021 CIM 2021-NR1 232,682 162,877 69,805 213,809 142,125 71,684 2020 CIM 2020-NR1(1) 131,860 84,165 47,695 124,253 76,638 47,615 2020 CIM 2020-R7(2) 653,192 562,023 91,169 589,066 497,894 91,172 2020 CIM 2020-R6 418,390 334,151 84,239 374,835 290,516 84,319 2020 CIM 2020-R5 338,416 257,027 81,389 267,138 185,460 81,678 2020 CIM 2020-R4 276,316 207,237 69,079 248,991 179,761 69,230 2020 CIM 2020-R3 438,228 328,670 109,558 370,633 261,120 109,513 2020 CIM 2020-R2 492,347 351,926 140,421 418,084 343,686 74,398 2020 CIM 2020-R1 390,761 317,608 73,153 341,229 268,131 73,098 2019 CIM 2019-R5 315,039 252,224 62,815 242,466 179,752 62,714 2019 CIM 2019-R4 320,802 200,000 120,802 256,852 192,691 64,161 2019 CIM 2019-R3(2) 342,633 291,237 51,396 254,962 203,226 51,736 2019 CIM 2019-R2 464,327 358,172 106,155 388,199 283,507 104,692 2019 CIM 2019-R1 371,762 297,409 74,353 306,156 232,071 74,085 2018 CIM 2018-R6(1) 478,251 334,775 143,476 315,059 173,973 141,086 2018 CIM 2018-R5(1) 380,194 266,136 114,058 234,838 123,673 111,165 2018 CIM 2018-R3 181,073 146,669 34,404 102,991 69,654 33,337 2017 CMLTI 2017-RP2(1) 421,329 341,276 80,053 266,121 201,418 64,703 2017 CIM 2017-7 512,446 341,062 171,384 315,938 159,264 156,674 2016 CIM 2016-FRE1(1) 185,811 115,165 70,646 97,576 37,336 60,240 2012 CSMC 2012-CIM3 329,886 305,804 24,082 35,526 27,540 7,986 2008 PHHMC 2008-CIM1 619,710 549,142 70,568 12,973 9,594 3,379 TOTAL $13,654,469 $10,918,268 $2,736,201 $10,835,456 $8,343,475 $2,491,981 All data as of June 30, 2021 $ in thousands (1) Currently callable or callable during 2021 (2) Accounted for as a secured borrowing CONSOLIDATED LOAN SECURITIZATIONS


 
chimerareit.com